Hematological Malignancies

First page Previous page 1389 Next page Last page

Targeted chemotherapy in clinical development

Antibody-drug conjugates

Polatuzumab Vedotin Target CD79b

Target CD22

Goy A, et al. Blood . 2010;116(21): Abstract 430.

Made with